Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Aug;25(4):231-236.
doi: 10.1097/MED.0000000000000421.

Bone health in type 1 diabetes

Viral N Shah  1 , R Dana Carpenter  2 , Virginia L Ferguson  3 , Ann V Schwartz  4
Affiliations
Review

Bone health in type 1 diabetes

Viral N Shah et al. Curr Opin Endocrinol Diabetes Obes. 2018 Aug.

Abstract

Purpose of review: This article reviews recent publications on the effect of type 1 diabetes (T1D) on fracture risk, bone mineral density (BMD), bone structure, and bone tissue quality. Possible fracture prevention strategies for patients with T1D have also been reviewed.

Recent findings: T1D is associated with substantially elevated fracture risk and modestly low BMD at the femoral neck. However, BMD alone does not explain higher observed fracture risk in T1D. T1D also affects bone macro- and microstructure, characterized by thinner cortices and trabecular bone changes such as thinner and more widely spaced trabeculae. Structural bone deficit is pronounced in the presence of microvascular complications. Tissue-level changes, such as accumulation of advanced glycation endproducts, detrimental alterations of the mineral phase because of low bone turnover, and occlusion of vascular channels in bone by mineralized tissue, are implicated in pathophysiology of bone fragility in T1D. There are no guidelines on screening and prevention of osteoporotic fractures in T1D.

Summary: More studies are needed to understand the influence of T1D on structural bone quality and tissue material properties. There is a need for a prospective study to evaluate better screening strategies for diagnosis and treatment of osteoporosis in T1D.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest

V.N.S. conceptualize the idea. V.N.S, R.D.C., and C.F. wrote the first draft of the manuscript. A.V.S. edited and reviewed the manuscript.

There are no conflicts of interest.

References

    1. Skyler JS. Hope vs hype: where are we in type 1 diabetes? Diabetologia 2018; 61:509–516. - PubMed
    1. Gagnum V, Saeed M, Stene LC, et al. Low incidence of end-stage renal disease in childhood-onset type 1 diabetes followed for up to 42 years. Diabetes Care 2018; 41:420–425. - PubMed
    1. Rawshani A, Rawshani A, Franzén S, et al. Mortality and cardiovascular disease in type 1 and type 2 diabetes. N Engl J Med 2017; 376:1407–1418. - PubMed
    1. Gagnum V, Stene LC, Leivestad T, et al. Long-term mortality and end-stage renal disease in a type 1 diabetes population diagnosed at age 15-29 years in Norway. Diabetes Care 2017; 40:38–45. - PubMed
    1. Palermo A, D’Onofrio L, Buzzetti R, et al. Pathophysiology of bone fragility in patients with diabetes. Calcif Tissue Int 2017; 100:122–132. - PubMed

Publication types

MeSH terms